Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2026-02-24 @ 5:07 AM
Study NCT ID:
NCT02072668
Status:
COMPLETED
Last Update Posted:
2020-04-13
First Post:
2014-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Effect of Rivaroxaban in Sickle Cell Disease
Sponsor:
University of North Carolina, Chapel Hill
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
12-2607
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |